Medications
FDA approves once-a-day inhaler from Glaxo
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.
May 10, 2013
0
0
Chronic Bronchitis
Medications
US panel backs inhaler drug for lung disease
A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.
Apr 17, 2013
0
0
Addiction
Cigarette relighting tied to tough economy
In what is believed to be a first of its kind study, a research member at The Cancer Institute of New Jersey and colleagues have found that an accelerating trend of smokers relighting cigarettes is related to economic factors, ...
Mar 23, 2013
1
0
Medications
Frequently prescribed drug used in concerning ways with harmful side effects
A popular class of drugs commonly used to treat sleep and mood symptoms continues to be frequently prescribed despite being known to have potentially life-threatening side effects.
Feb 6, 2013
0
0
Medications
FDA panel backs long-acting Boehringer inhaler
(AP)—A panel of federal health experts is overwhelmingly recommending approval for a long-acting inhaler to treat people suffering from chronic lung disease.
Jan 29, 2013
0
0
Diseases, Conditions, Syndromes
World's largest respiratory genetics study launches on World COPD Day
Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.
Nov 14, 2012
0
0
Medical research
Scattered X-rays improve early detection of pulmonary disease
Severe lung diseases are among the leading causes of death worldwide. To date they have been difficult to diagnose at an early stage. Within an international collaboration scientists from Munich now developed an X-ray technology ...
Oct 22, 2012
0
0
Diseases, Conditions, Syndromes
College education and moderate alcohol intake linked to lower COPD risk
College education and alcohol consumption may be linked to risk for chronic obstructive pulmonary disease (COPD). Researchers from Kaiser Permanente Medical Group in Oakland, California, followed 126,019 people who supplied ...
Oct 22, 2012
0
0
Medications
Roflumilast improves lung function after 6 months compared with placebo
Roflumilast was associated with significant improvements in lung function in patients with moderate and severe chronic obstructive pulmonary disease (COPD) after 6 months of treatment compared with placebo.
Oct 22, 2012
0
0
Diseases, Conditions, Syndromes
Tudorza pressair approved for COPD
(HealthDay) -- The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) ...
Jul 24, 2012
0
1
